Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Boshoff

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Bioorganic & Medicinal Chemistry|March 7, 2012
Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffoldsGarrett C Moraski, Lowell D Markley, Mayland Chang, et al.
Journal of the American Society for Mass Spectrometry|March 22, 2003
Top down characterization of secreted proteins from Mycobacterium tuberculosis by electron capture dissociation mass spectrometryYing Ge, Mariam El-Naggar, Siu Kwan Sze, et al.
ACS Medicinal Chemistry Letters|August 10, 2013
Advancement of Imidazo[1,2-<i>a</i>]pyridines with Improved Pharmacokinetics and Nanomolar Activity Against <i>Mycobacterium tuberculosis.</i>Garrett C Moraski, Lowell D Markley, Jeffrey Cramer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2006
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosisUjjini H Manjunatha, Helena Boshoff, Cynthia S Dowd, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Identification of Antifungal Compounds against Multidrug-Resistant Candida auris Utilizing a High-Throughput Drug-Repurposing ScreenYu-Shan Cheng, Jose Santinni Roma, Min Shen, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosisSantiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensisSuresh Kumar Gorla, Yan Zhang, Meaghan M Rabideau, et al.
Tuberculosis (Edinburgh, Scotland)|February 5, 2013
Updating and curating metabolic pathways of TBRichard A Slayden, Mary Jackson, Jeremy Zucker, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bioorganic & Medicinal Chemistry|March 7, 2012
Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffoldsGarrett C Moraski, Lowell D Markley, Mayland Chang, et al.
Journal of the American Society for Mass Spectrometry|March 22, 2003
Top down characterization of secreted proteins from Mycobacterium tuberculosis by electron capture dissociation mass spectrometryYing Ge, Mariam El-Naggar, Siu Kwan Sze, et al.
ACS Medicinal Chemistry Letters|August 10, 2013
Advancement of Imidazo[1,2-<i>a</i>]pyridines with Improved Pharmacokinetics and Nanomolar Activity Against <i>Mycobacterium tuberculosis.</i>Garrett C Moraski, Lowell D Markley, Jeffrey Cramer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2006
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosisUjjini H Manjunatha, Helena Boshoff, Cynthia S Dowd, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Identification of Antifungal Compounds against Multidrug-Resistant Candida auris Utilizing a High-Throughput Drug-Repurposing ScreenYu-Shan Cheng, Jose Santinni Roma, Min Shen, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosisSantiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensisSuresh Kumar Gorla, Yan Zhang, Meaghan M Rabideau, et al.
Tuberculosis (Edinburgh, Scotland)|February 5, 2013
Updating and curating metabolic pathways of TBRichard A Slayden, Mary Jackson, Jeremy Zucker, et al.
Pageof 2